PMC:7247521 / 37909-38544 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"626","span":{"begin":66,"end":74},"obj":"Disease"},{"id":"627","span":{"begin":316,"end":319},"obj":"Disease"}],"attributes":[{"id":"A626","pred":"tao:has_database_id","subj":"626","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Evaluation of the effect of QFPD on the robustness disturbance of COVID-19 network. Blue normal distribution: drug attack on random networks as a null distribution for the permutation test. Red vertical line: the disturbance rate of the drug to the real disease network. Fist row: MXSG, second row: SGMH, third row: XCH, fourth row: WLS, fifth row: Others. Fist column: average connectivity, second row: average length of shortest path, third row: connection centrality, fourth row: closeness centrality. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T578","span":{"begin":66,"end":74},"obj":"SP_7"},{"id":"T579","span":{"begin":110,"end":114},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T580","span":{"begin":237,"end":241},"obj":"CHEBI:23888;CHEBI:23888"}],"text":"Evaluation of the effect of QFPD on the robustness disturbance of COVID-19 network. Blue normal distribution: drug attack on random networks as a null distribution for the permutation test. Red vertical line: the disturbance rate of the drug to the real disease network. Fist row: MXSG, second row: SGMH, third row: XCH, fourth row: WLS, fifth row: Others. Fist column: average connectivity, second row: average length of shortest path, third row: connection centrality, fourth row: closeness centrality. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T71","span":{"begin":66,"end":74},"obj":"Disease"}],"attributes":[{"id":"A71","pred":"mondo_id","subj":"T71","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Evaluation of the effect of QFPD on the robustness disturbance of COVID-19 network. Blue normal distribution: drug attack on random networks as a null distribution for the permutation test. Red vertical line: the disturbance rate of the drug to the real disease network. Fist row: MXSG, second row: SGMH, third row: XCH, fourth row: WLS, fifth row: Others. Fist column: average connectivity, second row: average length of shortest path, third row: connection centrality, fourth row: closeness centrality. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T327","span":{"begin":144,"end":145},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T328","span":{"begin":184,"end":188},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"Evaluation of the effect of QFPD on the robustness disturbance of COVID-19 network. Blue normal distribution: drug attack on random networks as a null distribution for the permutation test. Red vertical line: the disturbance rate of the drug to the real disease network. Fist row: MXSG, second row: SGMH, third row: XCH, fourth row: WLS, fifth row: Others. Fist column: average connectivity, second row: average length of shortest path, third row: connection centrality, fourth row: closeness centrality. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T322","span":{"begin":110,"end":114},"obj":"Chemical"},{"id":"T323","span":{"begin":237,"end":241},"obj":"Chemical"}],"attributes":[{"id":"A322","pred":"chebi_id","subj":"T322","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A323","pred":"chebi_id","subj":"T323","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"Evaluation of the effect of QFPD on the robustness disturbance of COVID-19 network. Blue normal distribution: drug attack on random networks as a null distribution for the permutation test. Red vertical line: the disturbance rate of the drug to the real disease network. Fist row: MXSG, second row: SGMH, third row: XCH, fourth row: WLS, fifth row: Others. Fist column: average connectivity, second row: average length of shortest path, third row: connection centrality, fourth row: closeness centrality. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)"}

{"project":"LitCovid-sentences","denotations":[{"id":"T280","span":{"begin":84,"end":189},"obj":"Sentence"},{"id":"T281","span":{"begin":190,"end":270},"obj":"Sentence"},{"id":"T282","span":{"begin":271,"end":348},"obj":"Sentence"},{"id":"T283","span":{"begin":349,"end":356},"obj":"Sentence"},{"id":"T284","span":{"begin":357,"end":635},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Evaluation of the effect of QFPD on the robustness disturbance of COVID-19 network. Blue normal distribution: drug attack on random networks as a null distribution for the permutation test. Red vertical line: the disturbance rate of the drug to the real disease network. Fist row: MXSG, second row: SGMH, third row: XCH, fourth row: WLS, fifth row: Others. Fist column: average connectivity, second row: average length of shortest path, third row: connection centrality, fourth row: closeness centrality. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)"}